Thus, in advanced colon cancer (CRC), high levels of MMP-12 have been associated with better prognosis, while increased levels of TIMP, the negative tissue regulator of MMP, correlated with a negative prognosis in that cancer [83]. This evidence concerns the gene TIMP1 and colonic neoplasm.